• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期康复的鼠疫患者对鼠疫耶尔森菌感染的体液免疫和细胞免疫反应。

Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.

作者信息

Li Bei, Du Chunhong, Zhou Lei, Bi Yujing, Wang Xiaoyi, Wen Li, Guo Zhaobiao, Song Zhizhong, Yang Ruifu

机构信息

Institute of Biomedicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei Province, China.

出版信息

Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21.

DOI:10.1128/CVI.05559-11
PMID:22190397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3272935/
Abstract

Plague is one of the most dangerous diseases and is caused by Yersinia pestis. Effective vaccine development requires understanding of immune protective mechanisms against the bacterium in humans. In this study, the humoral and memory cellular immune responses in plague patients (n = 65) recovered from Y. pestis infection during the past 16 years were investigated using a protein microarray and an enzyme-linked immunosorbent spot assay (ELISpot). The seroprevalence to the F1 antigen in all recovered patients is 78.5%. In patients infected more than a decade ago, the antibody-positive rate still remains 69.5%. There is no difference in the antibody presence between gender, age, and infected years, but it seems to be associated with the F1 antibody titers during infection (r = 0.821; P < 0.05). Except F1 antibody, the antibodies against LcrV and YopD were detected in most of the patients, suggesting they could be the potential diagnostic markers for detecting the infection of F1-negative strains. Regarding cellular immunity, the cell number producing gamma interferon (IFN-γ), stimulated by F1 and LcrV, respectively, in vitro to the peripheral blood mononuclear cells of 7 plague patients and 4 negative controls, showed no significant difference, indicating F1 and LcrV are not dominant T cell antigens against plague for a longer time in humans. Our findings have direct implications for the future design and development of effective vaccines against Y. pestis infection and the development of new target-based diagnostics.

摘要

鼠疫是最危险的疾病之一,由鼠疫耶尔森菌引起。有效的疫苗研发需要了解人类针对该细菌的免疫保护机制。在本研究中,使用蛋白质微阵列和酶联免疫斑点测定法(ELISpot),对过去16年中从鼠疫耶尔森菌感染中康复的鼠疫患者(n = 65)的体液免疫和记忆细胞免疫反应进行了调查。所有康复患者中F1抗原的血清阳性率为78.5%。在十多年前感染的患者中,抗体阳性率仍为69.5%。抗体的存在在性别、年龄和感染年份之间没有差异,但似乎与感染期间的F1抗体滴度有关(r = 0.821;P < 0.05)。除F1抗体外,大多数患者还检测到了针对LcrV和YopD的抗体,这表明它们可能是检测F1阴性菌株感染的潜在诊断标志物。关于细胞免疫,分别用F1和LcrV体外刺激7例鼠疫患者和4例阴性对照的外周血单个核细胞后,产生γ干扰素(IFN-γ)的细胞数量没有显著差异,这表明在人类中,F1和LcrV在较长时间内不是针对鼠疫的主要T细胞抗原。我们的研究结果对未来针对鼠疫耶尔森菌感染的有效疫苗的设计和开发以及基于新靶点的诊断方法的开发具有直接意义。

相似文献

1
Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.长期康复的鼠疫患者对鼠疫耶尔森菌感染的体液免疫和细胞免疫反应。
Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21.
2
Delivery of antigens via outer membrane vesicles offered improved protection against plague.通过外膜囊泡传递抗原可提高对鼠疫的保护作用。
mSphere. 2024 Sep 25;9(9):e0033024. doi: 10.1128/msphere.00330-24. Epub 2024 Aug 19.
3
Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.马达加斯加鼠疫患者对鼠疫耶尔森氏菌的短期和长期体液免疫反应。
BMC Infect Dis. 2020 Nov 10;20(1):822. doi: 10.1186/s12879-020-05565-8.
4
A Recombinant Attenuated Vaccine Delivering a YopE-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.一种重组减毒疫苗传递 YopE-LcrV 融合蛋白,可在小鼠中引发针对鼠疫和耶尔森菌病的广泛保护。
Infect Immun. 2019 Sep 19;87(10). doi: 10.1128/IAI.00296-19. Print 2019 Oct.
5
Protecting against plague: towards a next-generation vaccine.预防鼠疫:迈向新一代疫苗。
Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044.
6
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.TNFα 和 IFNγ 有助于完全毒力肺鼠疫小鼠模型中针对 F1/LcrV 的免疫防御。
Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15.
7
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.体液和细胞免疫相关性保护免受鼠疫耶尔森菌活疫苗引起的腺鼠疫。
Vaccine. 2019 Jan 3;37(1):123-129. doi: 10.1016/j.vaccine.2018.11.022. Epub 2018 Nov 19.
8
Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.靶向鼠疫耶尔森氏菌 LcrV 毒力蛋白至树突状细胞可保护小鼠免受肺鼠疫感染。
Eur J Immunol. 2010 Oct;40(10):2791-6. doi: 10.1002/eji.201040511.
9
Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.评估鼠疫耶尔森菌外膜蛋白抗原作为新一代重组鼠疫疫苗潜在候选物的保护潜力。
Clin Vaccine Immunol. 2013 Feb;20(2):227-38. doi: 10.1128/CVI.00597-12. Epub 2012 Dec 12.
10
Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.肠侵袭性大肠杆菌 lcrV 基因多态性及其对鼠疫保护性免疫的影响。
Infect Immun. 2012 Apr;80(4):1572-82. doi: 10.1128/IAI.05637-11. Epub 2012 Jan 17.

引用本文的文献

1
Delivery of antigens via outer membrane vesicles offered improved protection against plague.通过外膜囊泡传递抗原可提高对鼠疫的保护作用。
mSphere. 2024 Sep 25;9(9):e0033024. doi: 10.1128/msphere.00330-24. Epub 2024 Aug 19.
2
Remodeling to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague.改造以产生针对肺鼠疫的高免疫原性外膜囊泡疫苗。
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2109667119. doi: 10.1073/pnas.2109667119. Epub 2022 Mar 11.
3
Peptidoglycan-Free Bacterial Ghosts Confer Enhanced Protection against Infection.无肽聚糖细菌幽灵赋予增强的抗感染保护作用。
Vaccines (Basel). 2021 Dec 30;10(1):51. doi: 10.3390/vaccines10010051.
4
Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens.分泌系统组件作为细菌病原体的潜在预防靶点。
Biomolecules. 2021 Jun 15;11(6):892. doi: 10.3390/biom11060892.
5
Has a Cellular Immune Response Profile Distinct from Laboratory Mice.具有与实验室小鼠不同的细胞免疫反应特征。
Viruses. 2021 Apr 22;13(5):729. doi: 10.3390/v13050729.
6
Field assessment of dog as sentinel animal for plague in endemic foci of Madagascar.马达加斯加鼠疫流行地区用狗作为鼠疫哨源动物的现场评估
Integr Zool. 2021 Nov;16(6):886-892. doi: 10.1111/1749-4877.12541. Epub 2021 May 18.
7
Protection Elicited by Attenuated Live Vaccine Strains against Lethal Infection with Virulent .减毒活疫苗株诱导的针对强毒株致死性感染的保护作用
Vaccines (Basel). 2021 Feb 16;9(2):161. doi: 10.3390/vaccines9020161.
8
Outer Membrane Vesicles as Potential Vaccine Candidates in Protecting against Plague.外膜囊泡作为预防鼠疫的潜在疫苗候选物。
Biomolecules. 2020 Dec 18;10(12):1694. doi: 10.3390/biom10121694.
9
Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine-Comparison of Immunoinformatic and Immunological Approaches.抗原F1而非LcrV在接种活鼠疫疫苗的人体中诱导体液免疫和细胞免疫反应——免疫信息学与免疫学方法的比较
Vaccines (Basel). 2020 Nov 19;8(4):698. doi: 10.3390/vaccines8040698.
10
Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.马达加斯加鼠疫患者对鼠疫耶尔森氏菌的短期和长期体液免疫反应。
BMC Infect Dis. 2020 Nov 10;20(1):822. doi: 10.1186/s12879-020-05565-8.

本文引用的文献

1
T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.T 细胞在抗 F1 介导的抗鼠疫快速保护中发挥着重要作用。
Vaccine. 2011 Sep 16;29(40):6866-73. doi: 10.1016/j.vaccine.2011.07.059. Epub 2011 Jul 29.
2
Serum cytokine responses in primary pneumonic plague patients.原发性肺鼠疫患者的血清细胞因子反应。
Clin Vaccine Immunol. 2011 Jan;18(1):184-6. doi: 10.1128/CVI.00386-10. Epub 2010 Nov 24.
3
Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis.基于上转换荧光粉技术的 10 通道侧向流动分析方法的开发,用于分析针对鼠疫耶尔森氏菌的抗体。
J Microbiol Methods. 2010 Nov;83(2):133-40. doi: 10.1016/j.mimet.2010.08.005. Epub 2010 Aug 27.
4
Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.比较评估鼠疫亚单位疫苗 F1+rV270 的小鼠、豚鼠和兔模型。
Vaccine. 2010 Feb 10;28(6):1655-60. doi: 10.1016/j.vaccine.2009.02.078. Epub 2009 Mar 9.
5
Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice.鼠疫耶尔森菌亚单位疫苗F1-rV270对小鼠的长期观察
Clin Vaccine Immunol. 2010 Jan;17(1):199-201. doi: 10.1128/CVI.00305-09. Epub 2009 Nov 25.
6
High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.通过酶联免疫斑点测定法从鼠疫耶尔森氏菌活疫苗中高通量鉴定新的保护性抗原
Infect Immun. 2009 Oct;77(10):4356-61. doi: 10.1128/IAI.00242-09. Epub 2009 Aug 3.
7
Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay.基于上转换磷光技术的侧向流动分析法快速定量检测布鲁氏菌
J Microbiol Methods. 2009 Oct;79(1):121-3. doi: 10.1016/j.mimet.2009.07.015. Epub 2009 Jul 25.
8
Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody.基于上转换荧光粉技术的侧向流动分析法用于快速定量检测乙型肝炎表面抗体的研究进展
Diagn Microbiol Infect Dis. 2009 Feb;63(2):165-72. doi: 10.1016/j.diagmicrobio.2008.10.020.
9
Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray.用于鼠疫监测的哨兵动物血清学调查以及通过蛋白质微阵列筛选F1抗原的补充诊断标志物。
Am J Trop Med Hyg. 2008 Nov;79(5):799-802.
10
Yersinia pestis caf1 variants and the limits of plague vaccine protection.鼠疫耶尔森菌caf1变体与鼠疫疫苗保护的局限性
Infect Immun. 2008 May;76(5):2025-36. doi: 10.1128/IAI.00105-08. Epub 2008 Mar 17.